Related Experiment Video
Updated: May 8, 2026
09:17
Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
Animal models of sepsis
1Departments of Surgery and Anesthesiology; David Geffen School of Medicine at UCLA; Los Angeles, CA USA.
Virulence
|September 12, 2013
Summary
Developing new sepsis treatments faces challenges due to unreliable animal models. Differences in gene expression and toxin sensitivity between animals and humans lead to misleading preclinical results for sepsis therapies.
Area of Science:
- Critical care medicine
- Translational research
- Pharmacology
Background:
- Sepsis is a complex, heterogeneous condition with significant public health impact.
- Therapeutic development for sepsis has faced consistent failure in clinical trials.
- Existing animal models for sepsis research often produce misleading results.
Purpose of the Study:
- To evaluate the utility of animal models in preclinical sepsis research.
- To identify reasons for discrepancies between animal model findings and human clinical trial outcomes.
- To inform the development of more predictive models for sepsis therapies.
Main Methods:
- Review of existing literature on animal models for sepsis.
- Analysis of discrepancies in gene expression patterns between species.
- Comparison of species' sensitivity to bacterial endotoxins.
Main Results:
- Animal models frequently yield misleading data for sepsis drug development.
- Significant differences in trauma/infection-induced gene expression exist between mice and humans.
- Mice and baboons exhibit high resistance to lipopolysaccharide toxicity, unlike humans.
Conclusions:
- Current animal models for sepsis research require critical re-evaluation.
- Preclinical findings in sepsis drug development warrant a degree of skepticism.
- Further investigation into species-specific responses is crucial for advancing sepsis therapeutics.
